Serum neurofilament light chain as a biomarker in pediatric demyelinating disease with and without myelitis

被引：0
|
作者：
Levine, J. M.
Kannan, V
Fisher, K. S.
机构：
来源：
ANNALS OF NEUROLOGY | 2025年 / 96卷
关键词：
Pediatric Demyelinating Disease; Neuroimmunology; Neuroimaging;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
308
引用
收藏
页码：S135 / S136
页数：2
相关论文
共 50 条
  • [41] Neurofilament Light Chain as a Biomarker in Cerebral Small-Vessel Disease
    Peters, Nils
    MOLECULAR DIAGNOSIS & THERAPY, 2022, 26 (01) : 1 - 6
  • [42] Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
    Varhaug, Kristin N.
    Torkildsen, Oivind
    Myhr, Kjell-Morten
    Vedeler, Christian A.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [43] Neurofilament Light Chain as A Biomarker for Brain Metastases
    Winther-Larsen, Anne
    Hviid, Claus Vinter Bodker
    Meldgaard, Peter
    Sorensen, Boe Sandahl
    Sandfeld-Paulsen, Birgitte
    CANCERS, 2020, 12 (10) : 1 - 10
  • [44] Neurofilament light chain as a biomarker in neurological disorders
    Gaetani, Lorenzo
    Blennow, Kaj
    Calabresi, Paolo
    Di Filippo, Massimiliano
    Parnetti, Lucilla
    Zetterberg, Henrik
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (08): : 870 - 881
  • [45] Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy
    Kapoor, Mahima
    Carr, Aisling
    Foiani, Martha
    Heslegrave, Amanda
    Zetterberg, Henrik
    Malaspina, Andrea
    Compton, Laura
    Hutton, Elspeth
    Rossor, Alexander
    Reilly, Mary M.
    Lunn, Michael P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (11) : 3347 - 3357
  • [46] Serum Glial Fibrillary Acidic Protein compared with Neurofilament Light Chain as Biomarker for Multiple Sclerosis Disease Progression
    Meier, Stephanie
    Benkert, Pascal
    Maceski, Aleksandra Maleska
    Schaedelin, Sabine
    Oechtering, Johanna
    Melie-Garcia, Lester
    Cagol, Alessandro
    Barakovic, Muhamed
    Galbusera, Riccardo
    Achtnichts, Lutz
    Lalive, Patrice H.
    Bridel, Claire
    Mueller, Stefanie
    Pot, Caroline
    Salmen, Anke
    Disanto, Giulio
    Zecca, Chiara
    Abdelhak, Ahmed
    Barro, Christian
    Thebault, Simon
    D'Souza, Marcus
    Derfuss, Tobias
    Orleth, Annette
    Khalil, Michael
    Yaldizli, Ozguer
    Hermesdorf, Marco
    Wiendl, Heinz
    Piehl, Fredrik
    Fischer, Urs
    Kappos, Ludwig
    Gobbi, Claudio
    Granziera, Cristina
    Leppert, David
    Willemse, Eline A. J.
    Kuhle, Jens
    NEUROLOGY, 2023, 100 (17)
  • [47] Serum Neurofilament Light Chain Levels as a Biomarker of Disease Activity, Progression and Treatment Response in Patients with Multiple Sclerosis
    Fabis-Pedrini, Marzena
    Kaskow, Belinda
    Trend, Stephanie
    Carroll, William
    Walters, Sue
    Maceski, Aleksandra
    Kuhle, Jens
    Kermode, Allan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP2 - NP2
  • [48] Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis
    Meier, Stephanie
    Willemse, Eline A. J.
    Schaedelin, Sabine
    Oechtering, Johanna
    Lorscheider, Johannes
    Melie-Garcia, Lester
    Cagol, Alessandro
    Barakovic, Muhamed
    Galbusera, Riccardo
    Subramaniam, Suvitha
    Barro, Christian
    Abdelhak, Ahmed
    Thebault, Simon
    Achtnichts, Lutz
    Lalive, Patrice
    Muller, Stefanie
    Pot, Caroline
    Salmen, Anke
    Disanto, Giulio
    Zecca, Chiara
    D'Souza, Marcus
    Orleth, Annette
    Khalil, Michael
    Buchmann, Arabella
    Du Pasquier, Renaud
    Yaldizli, Ozgur
    Derfuss, Tobias
    Berger, Klaus
    Hermesdorf, Marco
    Wiendl, Heinz
    Piehl, Fredrik
    Battaglini, Marco
    Fischer, Urs
    Kappos, Ludwig
    Gobbi, Claudio
    Granziera, Cristina
    Bridel, Claire
    Leppert, David
    Maceski, Aleksandra Maleska
    Benkert, Pascal
    Kuhle, Jens
    JAMA NEUROLOGY, 2023, 80 (03) : 287 - 297
  • [49] Serum glial fibrillary acidic protein compared with neurofilament light chain as biomarker for multiple sclerosis disease progression
    Meier, S.
    Benkert, P.
    Maceski, A.
    Schaedelin, S.
    Garcia, L. Melie
    Cagol, A.
    Barakovic, M.
    Galbusera, R.
    Subramaniam, S.
    Achtnichts, L.
    Lalive, P. H.
    Bridel, C.
    Muller, S.
    Pot, C.
    Salmen, A.
    Disanto, G.
    Zecca, C.
    Orleth, A.
    Khalil, M.
    Yaldizli, O.
    Oechtering, J.
    Battaglini, M.
    Kappos, L.
    Derfuss, T.
    Leppert, D.
    Gobbi, C.
    Granziera, C.
    Willemse, E. A. J.
    Kuhle, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 122 - 123
  • [50] Chitinase 3-like 1 and neurofilament light chain in the cerebrospinal fluid predict pediatric acquired CNS demyelinating disease
    Boesen, M. S.
    Jensen, P. E.
    Magyari, M.
    Born, A. P.
    Uldall, P.
    Blinkenberg, M.
    Sellebjerg, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 108 - 109
12345